An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)
Clinical trial NCT01670981 · COMPLETED
Trial details
- NCT number
- NCT01670981
- Sponsor
- Vericel Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-20
- Primary completion
- 2016-02-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.